BA Pharma SRL
5.2 FTEThe score of BA Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +1 % Total assets 0 % Headcount (avg FTE) +206 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
BA Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Jul 2026
- Year ended 31 Dec 2024filed on 20 Jun 2025
- Year ended 31 Dec 2023filed on 09 Jul 2024
- Year ended 31 Dec 2022filed on 08 Jun 2023
- Year ended 31 Dec 2021filed on 13 Jun 2022
BA Pharma's financial analysis
- Solvency6.6%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of BA Pharma
BA Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0715.554.548
- VAT number
- BE0715554548
- Peppol
- Registered · 0208:0715554548 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 06 Dec 2018
- Registered office
- 6250 Aiseau-Presles
- Size
- Micro · 5.2 FTE
- Latest accounts
- 2025 · filed on 28 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
BA Pharma (SRL) has been based in Aiseau-Presles since 2018, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 689 € and equity of 146,387 €; its revenue is not published. With 5.2 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 6.6%, below the median of its sector (41.5%).
Companies similar to BA Pharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Barbarin Laurence Retail sale of pharmaceutical products Les Bons Villers · balance sheet €2.19m
- Cityphar Retail sale of pharmaceutical products Ixelles · balance sheet €2.22m
- Alphar Braine-LE-Comte Retail sale of pharmaceutical products Braine-le-Comte · balance sheet €2.21m
- Nagels Retail sale of pharmaceutical products Stabroek · balance sheet €2.22m
- Apotheek Cindy Nachtergaele Retail sale of pharmaceutical products Kruisem · balance sheet €2.22m
- Omnimed Retail sale of pharmaceutical products Kalmthout · balance sheet €2.22m
- F. Rodenbach Retail sale of pharmaceutical products Zulte · balance sheet €2.25m
- Almey-De Groote Retail sale of pharmaceutical products Kaprijke · balance sheet €2.16m
Frequently asked questions about BA Pharma
What is the revenue of BA Pharma?
BA Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of BA Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0715554548 for BA Pharma, if the company is VAT-registered. Its company number (CBE) is 0715.554.548.
Where is the registered office of BA Pharma?
According to the CBE register, the registered office of BA Pharma is in 6250 Aiseau-Presles.
What is the equity of BA Pharma?
At the close of the 2025 financial year, the equity of BA Pharma amounts to 146,387 €, a solvency of 6.6% of total assets.
How many people work at BA Pharma?
5.2 full-time equivalents on average according to the 2025 social balance sheet.
Who manages BA Pharma?
The register lists 1 active mandates at BA Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of BA Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →